NCT02162849 2026-02-09
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
Clinical Trials
3 trialsNCT06077487 2025-05-21
Ketamine-assisted Therapy for Advanced GI Cancer
University of California, San Francisco
Phase 4 Terminated
NCT03289741 2025-05-09
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Memorial Sloan Kettering Cancer Center
Phase 4 Completed